SVB Leerink Comments on Ultragenyx Pharmaceutical Inc.’s Fiscal Year 2024 Results (NASDAQ: RARE)
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) - Equity researchers SVB Leerink released their fiscal 2024 earnings per share (EPS) estimates for shares...